Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C50H86O35P4 |
Molecular Weight | 1371.0919 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCO[C@@H]1[C@H](OC(=O)CCC)[C@H](OP(=O)(OCOC(=O)CC)OCOC(=O)CC)[C@@H](OP(=O)(OCOC(=O)CC)OCOC(=O)CC)[C@H](OP(=O)(OCOC(=O)CC)OCOC(=O)CC)[C@H]1OP(=O)(OCOC(=O)CC)OCOC(=O)CC
InChI
InChIKey=SVJGGWZOTSJMCQ-RMTIMQEASA-N
InChI=1S/C50H86O35P4/c1-11-21-22-23-24-25-27-64-45-46(81-44(59)26-12-2)48(83-87(61,75-30-67-38(53)15-5)76-31-68-39(54)16-6)50(85-89(63,79-34-71-42(57)19-9)80-35-72-43(58)20-10)49(84-88(62,77-32-69-40(55)17-7)78-33-70-41(56)18-8)47(45)82-86(60,73-28-65-36(51)13-3)74-29-66-37(52)14-4/h45-50H,11-35H2,1-10H3/t45-,46+,47+,48+,49-,50-/m1/s1
Molecular Formula | C50H86O35P4 |
Molecular Weight | 1371.0919 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
INO-4995, a synthetic analog of the intracellular signaling molecule, D-myo-inositol 3,4,5,6-tetrakisphosphate, regulates airway secretory and absorptive processes, affecting mucosal hydration by prolonged inhibition of Na(+) and fluid absorption in cystic fibrosis (CF) human nasal epithelia. At the moment INO-4995 is in preclinical development for CF treatment.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Inositol polyphosphate derivative inhibits Na+ transport and improves fluid dynamics in cystic fibrosis airway epithelia. | 2005 Sep |
|
INO-4995 therapeutic efficacy is enhanced with repeat dosing in cystic fibrosis knockout mice and human epithelia. | 2010 Jan |
|
Control of TMEM16A by INO-4995 and other inositolphosphates. | 2013 Jan |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22946960
Incubation of primary human airway epithelial and colonic cells with INO-4995 augmented 1.6- to 4-fold TMEM16A-dependent Cl(-) currents activated by ionomycin or ATP, while intracellular Ca(2+) signals were not affected.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:31:56 GMT 2023
by
admin
on
Sat Dec 16 05:31:56 GMT 2023
|
Record UNII |
3LM5SX2N4X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
169003
Created by
admin on Sat Dec 16 05:31:56 GMT 2023 , Edited by admin on Sat Dec 16 05:31:56 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
10148804
Created by
admin on Sat Dec 16 05:31:56 GMT 2023 , Edited by admin on Sat Dec 16 05:31:56 GMT 2023
|
PRIMARY | |||
|
3LM5SX2N4X
Created by
admin on Sat Dec 16 05:31:56 GMT 2023 , Edited by admin on Sat Dec 16 05:31:56 GMT 2023
|
PRIMARY |